Profil bibliographique

Dennie Tempel

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

73Publications signalées

3665Citations signalées

0Affiliations récentes

Domaines associés

Angiogenesis and VEGF in CancerAtherosclerosis and Cardiovascular DiseasesCoronary Interventions and DiagnosticsCutaneous Melanoma Detection and ManagementCytokine Signaling Pathways and Interactions

Publications récentes

2024 conference-abstractOpenAlex

Abstract 3780: From diagnostic labs to rapid near-patient testing: Bridging across RT-qPCR platforms of a clinicopathological and gene expression model for cutaneous melanoma patients

Lara Pozza, Sena Zümrütçü, Lizanne Bosman, Ashley van der Spek et autres

0 citationsCancer Research

Accès ouvert 2023 articleOpenAlex

Genomic investigations of unexplained acute hepatitis in children

Sofia Morfopoulou, Sarah Buddle, Oscar Enrique Torres Montaguth, Laura Atkinson et autres

139 citationsNature

Accès ouvert 2023 articleOpenAlex

Adeno-associated virus 2 infection in children with non-A–E hepatitis

Antonia Ho, Richard Orton, Rachel Tayler, Patawee Asamaphan et autres

176 citationsNature

2023 articleOpenAlex

Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse

Evalyn E.A.P. Mulder, Iva Johansson, Dirk J. Grünhagen, Dennie Tempel et autres

1 citationEuropean Journal of Surgical Oncology

2022 articleOpenAlex

Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis

Jennifer Venhorst, Tanja Rouhani Rankouhi, Daniëlle van Keulen, Dennie Tempel

6 citationsCurrent Drug Targets

Accès ouvert 2022 articleOpenAlex

Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay

Rowan Kuiper, Victoria Wright, Dominic Habgood-Coote, Chisato Shimizu et autres

15 citationsPediatric Research

Accès ouvert 2022 articleOpenAlex

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse

Evalyn E.A.P. Mulder, Iva Johansson, Dirk J. Grünhagen, Dennie Tempel et autres

28 citationsCancers

2022 conference-abstractOpenAlex

Use of Merlin Assay to identify patients with a low-risk for SN metastasis in a prospective multicenter Dutch study of a primary melanoma gene-signature (CP-GEP model) to predict sentinel node status during COVID-19.

Robert E. Stassen, Evalyn E.A.P. Mulder, Antoine Veringa, Antien L. Mooyaart et autres

3 citationsJournal of Clinical Oncology

Accès ouvert 2021 articleOpenAlex

Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary

Iva Johansson, Dennie Tempel, Jvalini Dwarkasing, Barbara Rentroia‐Pacheco et autres

35 citationsEuropean Journal of Surgical Oncology

Accès ouvert 2021 articleOpenAlex

Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study

Ahmed Yousaf, Félicia Tjien-Fooh, Barbara Rentroia‐Pacheco, Enrica Quattrocchi et autres

40 citationsInternational Journal of Dermatology

Accès ouvert 2021 articleOpenAlex

Common Variants Associated With OSMR Expression Contribute to Carotid Plaque Vulnerability, but Not to Cardiovascular Disease in Humans

Daniëlle van Keulen, Ian D. van Koeverden, Arjan Boltjes, Alain J. van Gool et autres

11 citationsFrontiers in Cardiovascular Medicine

2020 articleOpenAlex

1149P Validation of a model combining clinicopathologic risk factors and a gene expression profile to identify primary melanoma patients who can safely forgo sentinel lymph node biopsy

Alexander Meves, Ahmed Yousaf, Dennie Tempel, Mark Luna‐Vargas et autres

0 citationsAnnals of Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.